Brief: Lantern Pharma Inc. - Announced Expansions And Updates To RADR's Product Roadmap
15/02/2023 14:02
Feb 15 (Reuters) - Lantern Pharma Inc. LTRN.O :
* LANTERN PHARMA INC. - ANNOUNCED EXPANSIONS AND UPDATES TO
RADR'S
PRODUCT ROADMAP
* LANTERN PHARMA - RADR ADVANCEMENTS WILL FOCUS ON
ADDITIONAL
INNOVATIVE AI AND ML APPROACHES TO DEVELOP ANTIBODY DRUG
CONJUGATES
Source text for Eikon: ID:nBw50pFwja
Further company coverage: LTRN.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Lantern Pharma
See all newsBrief: Lantern Pharma Receives Taiwan Approvals To Open Next Stage Of Phase 2 Harmonic Trial Of Lp-300 In Never-Smoker, Egfr-Mutant Nsclc
Brief: Lantern Pharma Reports Second Quarter 2026 Financial Results And Provides Business Update
Lantern Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lantern Pharma Q2 operating loss widens on warrant expenses tied to higher stock price
Lantern Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview